{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:17:57Z","timestamp":1787987877948,"version":"build-2784847793"},"reference-count":34,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Cancer is associated with a significant short-term risk of venous thromboembolism (VTE). With substantial improvements in cancer survival, concern has been raised about an increased risk of VTE in long-term cancer survivors. We aimed to investigate the long-term risk of VTE in 5-year cancer survivors according to cancer subtype, age, and sex compared with a matched background population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Using Danish nationwide registries, we matched 5-year survivors of 21 cancers (\u226518 years; diagnosed 2000\u20132017; included 2005\u20132022 [5 years after cancer diagnosis]) with individuals from the background population (1:1 matching for the overall population and 1:4 matching for each cancer subtype). Rates of VTE were examined using Cox regression. In the overall population, 222 297 five-year cancer survivors were matched with 222 297 individuals from the background population (median age 69.2 years; 43.6% males). During a median follow-up of 5.6 years, cancer survivors had a higher associated rate of VTE compared with the background population (adjusted hazard ratio [aHR] 1.85 [95%CI, 1.78\u20131.93]). Survivors of all 21 cancer subtypes had a higher associated rate of VTE compared with the background population, with the highest incidence rates found for multiple myeloma. HRs were higher in younger cancer survivors compared with older cancer survivors (&amp;lt;50 years: aHR, 2.85 [95%CI, 2.33\u20133.47]; 50\u201364 years: aHR, 2.26 [95%CI, 2.07\u20132.46]; \u226565 years: aHR, 1.69 [95%CI, 1.61\u20131.77]; Pinteraction&amp;lt;0.0001). Similar HRs were found in females and males (females: aHR 1.84 [95%CI, 1.75\u20131.95]; males: aHR 1.86 [95%CI, 1.75\u20131.98]; Pinteraction=0.94).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Five-year cancer survivors had a higher associated rate of VTE compared with the background population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurjpc\/zwag439","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:51:12Z","timestamp":1787226672000},"source":"Crossref","is-referenced-by-count":0,"title":["Venous thromboembolism in 5-year cancer survivors: a nationwide cohort study"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3889-0080","authenticated-orcid":false,"given":"Adelina","family":"Yafasova","sequence":"first","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, Copenhagen University Hospital , Blegdamsvej 9, 2100 K\u00f8benhavn \u00d8, Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8888-379X","authenticated-orcid":false,"given":"Guoli","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, Copenhagen University Hospital , Blegdamsvej 9, 2100 K\u00f8benhavn \u00d8, Copenhagen ,","place":["Denmark"]},{"name":"Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People\u2019s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University , Guangzhou ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hutchings","sequence":"additional","affiliation":[{"name":"Department of Hematology, Rigshospitalet, Copenhagen University Hospital , 2100 Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiko N","family":"Doi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, Copenhagen University Hospital , Blegdamsvej 9, 2100 K\u00f8benhavn \u00d8, Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4271-2466","authenticated-orcid":false,"given":"Morten","family":"Schou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Herlev-Gentofte University Hospital , Herlev ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja V","family":"Maraldo","sequence":"additional","affiliation":[{"name":"Department of Oncology, Rigshospitalet, Copenhagen University Hospital , Copenhagen ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, University of Copenhagen , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna","family":"Alhakak","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, Copenhagen University Hospital , Blegdamsvej 9, 2100 K\u00f8benhavn \u00d8, Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4891-7358","authenticated-orcid":false,"given":"Nina","family":"Nouhravesh","sequence":"additional","affiliation":[{"name":"Department of Oncology, Rigshospitalet, Copenhagen University Hospital , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J V","family":"McMurray","sequence":"additional","affiliation":[{"name":"British Heart Foundation Cardiovascular Research Centre, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6333-9496","authenticated-orcid":false,"given":"Mark C","family":"Petrie","sequence":"additional","affiliation":[{"name":"British Heart Foundation Cardiovascular Research Centre, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninian N","family":"Lang","sequence":"additional","affiliation":[{"name":"British Heart Foundation Cardiovascular Research Centre, University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6635-1466","authenticated-orcid":false,"given":"Lars","family":"K\u00f8ber","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, Copenhagen University Hospital , Blegdamsvej 9, 2100 K\u00f8benhavn \u00d8, Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil L","family":"Fosb\u00f8l","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, Copenhagen University Hospital , Blegdamsvej 9, 2100 K\u00f8benhavn \u00d8, Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7380-4144","authenticated-orcid":false,"given":"Jawad H","family":"Butt","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, Copenhagen University Hospital , Blegdamsvej 9, 2100 K\u00f8benhavn \u00d8, Copenhagen ,","place":["Denmark"]},{"name":"Department of Hematology, Rigshospitalet, Copenhagen University Hospital , 2100 Copenhagen ,","place":["Denmark"]},{"name":"Department of Cardiology, Zealand University Hospital \u2013 Roskilde , 4000 Roskilde ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,29]]},"reference":[{"key":"2026082902165946900_zwag439-B1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA"},{"key":"2026082902165946900_zwag439-B2","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines: \u2002the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"2026082902165946900_zwag439-B3","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","article-title":"Shared risk factors in cardiovascular disease and cancer","volume":"133","author":"Koene","year":"2016","journal-title":"Circulation"},{"key":"2026082902165946900_zwag439-B4","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1158\/1055-9965.EPI-11-0729","article-title":"Cancer survivors: a booming population","volume":"20","author":"Parry","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026082902165946900_zwag439-B5","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.23.00294","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO guideline update","volume":"41","author":"Key","year":"2023","journal-title":"J Clin Oncol"},{"key":"2026082902165946900_zwag439-B6","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1093\/eurheartj\/ehab171","article-title":"Relative risk of arterial and venous thromboembolism in persons with cancer vs. Persons without cancer-a nationwide analysis","volume":"42","author":"Grilz","year":"2021","journal-title":"Eur Heart J"},{"key":"2026082902165946900_zwag439-B7","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.2020007338","article-title":"Venous thromboembolism in cancer patients: a population-based cohort study","volume":"137","author":"Mulder","year":"2021","journal-title":"Blood"},{"key":"2026082902165946900_zwag439-B8","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.amjmed.2021.01.031","article-title":"Increasing incidence and declining mortality after cancer-associated venous thromboembolism: a nationwide cohort study","volume":"134","author":"Ording","year":"2021","journal-title":"Am J Med"},{"key":"2026082902165946900_zwag439-B9","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1182\/blood-2013-04-460121","article-title":"Epidemiology of cancer-associated venous thrombosis","volume":"122","author":"Timp","year":"2013","journal-title":"Blood"},{"key":"2026082902165946900_zwag439-B10","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(19)31674-5","article-title":"Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases","volume":"394","author":"Strongman","year":"2019","journal-title":"Lancet"},{"key":"2026082902165946900_zwag439-B11","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejca.2017.07.013","article-title":"Sex differences in cancer risk and survival: a Swedish cohort study","volume":"84","author":"Radkiewicz","year":"2017","journal-title":"Eur J Cancer"},{"key":"2026082902165946900_zwag439-B12","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3390\/cancers17030378","article-title":"A pan-cancer analysis of age and sex differences in cancer incidence and survival in the United States, 2001\u20132020","volume":"17","author":"Selvaraj","year":"2025","journal-title":"Cancers (Basel)"},{"key":"2026082902165946900_zwag439-B13","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1200\/JCO.2007.11.2003","article-title":"Long-term health status among survivors of childhood cancer: does sex matter?","volume":"25","author":"Armstrong","year":"2007","journal-title":"J Clin Oncol"},{"key":"2026082902165946900_zwag439-B14","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish national patient registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"2026082902165946900_zwag439-B15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish national prescription registry","volume":"39","author":"Kildemoes","year":"2011","journal-title":"Scand J Public Health"},{"key":"2026082902165946900_zwag439-B16","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish civil registration system as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"2026082902165946900_zwag439-B17","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/pon.1208","article-title":"Multi-dimensional quality of life among long-term (5 + years) adult cancer survivors","volume":"16","author":"Bloom","year":"2007","journal-title":"Psychooncology"},{"key":"2026082902165946900_zwag439-B18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12955-018-0934-7","article-title":"Quality of life and physical activity in long-term (\u22655 years post-diagnosis) colorectal cancer survivors - systematic review","volume":"16","author":"Eyl","year":"2018","journal-title":"Health Qual Life Outcomes"},{"key":"2026082902165946900_zwag439-B19","first-page":"722","article-title":"Quality of ICD-10 colorectal cancer diagnosis codes in the Danish national registry of patients","volume":"21","author":"Helqvist","year":"2012","journal-title":"Eur J Cancer Care (Engl)"},{"key":"2026082902165946900_zwag439-B20","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/CEJ.0b013e328351c680","article-title":"Quality of urological cancer diagnoses in the Danish national registry of patients","volume":"21","author":"Gammelager","year":"2012","journal-title":"Eur J Cancer Prev"},{"key":"2026082902165946900_zwag439-B21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00008469-200506000-00002","article-title":"The data quality of haematological malignancy ICD-10 diagnoses in a population-based hospital discharge registry","volume":"14","author":"Norgaard","year":"2005","journal-title":"Eur J Cancer Prev"},{"key":"2026082902165946900_zwag439-B22","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1161\/CIRCULATIONAHA.107.720847","article-title":"Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people","volume":"117","author":"Schramm","year":"2008","journal-title":"Circulation"},{"key":"2026082902165946900_zwag439-B23","doi-asserted-by":"crossref","first-page":"d124","DOI":"10.1136\/bmj.d124","article-title":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study","volume":"342","author":"Olesen","year":"2011","journal-title":"BMJ (Clin Res Ed)"},{"key":"2026082902165946900_zwag439-B24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012832","article-title":"Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study","volume":"6","author":"Sundb\u00f8ll","year":"2016","journal-title":"BMJ Open"},{"key":"2026082902165946900_zwag439-B25","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2147\/CLEP.S423587","article-title":"The Danish National Child Health Register","volume":"15","author":"Andersen","year":"2023","journal-title":"Clin Epidemiol"},{"key":"2026082902165946900_zwag439-B26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-022-00336-y","article-title":"Cancer-associated venous thromboembolism","volume":"8","author":"Khorana","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"2026082902165946900_zwag439-B27","first-page":"Jco2018784595","article-title":"Long-term risk of venous thromboembolism in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study","author":"Madenci","year":"2018","journal-title":"J Clin Oncol"},{"key":"2026082902165946900_zwag439-B28","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/cncr.30364","article-title":"Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: a population-based cohort study","volume":"123","author":"Brand","year":"2017","journal-title":"Cancer"},{"key":"2026082902165946900_zwag439-B29","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1182\/blood-2015-01-625582","article-title":"When are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data","volume":"127","author":"Walker","year":"2016","journal-title":"Blood"},{"key":"2026082902165946900_zwag439-B30","first-page":"129","article-title":"Pulmonary embolism, part I: epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism","volume":"18","author":"B\u0115lohl\u00e1vek","year":"2013","journal-title":"Exp Clin Cardiol"},{"key":"2026082902165946900_zwag439-B31","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1055\/s-0038-1641678","article-title":"Long-term incidence of venous thromboembolism in cancer: the scandinavian thrombosis and cancer cohort","volume":"2","author":"Gade","year":"2018","journal-title":"TH Open"},{"key":"2026082902165946900_zwag439-B32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/2042098612452291","article-title":"Venous and arterial thrombotic risks with thalidomide: evidence and practical guidance","volume":"3","author":"Palumbo","year":"2012","journal-title":"Ther Adv Drug Saf"},{"key":"2026082902165946900_zwag439-B33","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1182\/blood-2013-04-460139","article-title":"Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients","volume":"122","author":"Geddings","year":"2013","journal-title":"Blood"},{"key":"2026082902165946900_zwag439-B34","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1200\/JCO.2015.64.0409","article-title":"Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study","volume":"34","author":"Armenian","year":"2016","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwag439\/70819199\/zwag439.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwag439\/70819199\/zwag439.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:17:05Z","timestamp":1787984225000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article\/doi\/10.1093\/eurjpc\/zwag439\/8771813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,29]]},"references-count":34,"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwag439","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,29]]},"article-number":"zwag439"}}